MDMs accumulate with age and participate in Aβ clearance [56, 57], however, their capacity to take up Aβ diminishes with age and AD progression, partially due to decreased expression of phagocytic receptors, such as TREM2 [56]. The gene discussed is TREM2; the disease is Alzheimer disease.